Lactobacillus fermentum
Evidence status
Limited evidence to recommend for any consumer outcome yet.
2 papers · 0 claims · 11 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
gastrointestinal symptoms (mild) mild
Any adverse event (aggregate)
Skin reactions (eczema/dermatitis/urticaria/etc.)
Sources
- 1. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes. (2011) ↑
- 2. Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study. (2022) ↑
Generated August 14, 2026